Literature DB >> 29472685

Pharmacology: MRONJ risk factor.

D Patel, V Patel.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29472685     DOI： 10.1038/sj.bdj.2018.132

Source DB:  PubMed          Journal:  Br Dent J        ISSN： 0007-0610            Impact factor:   1.626


× No keyword cloud information.
  2 in total

1.  Methotrexate-associated osteonecrosis of the jaw: A report of two cases.

Authors:  Marianne Henien; Barbara Carey; Esther Hullah; Chris Sproat; Vinod Patel
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2017-09-21

2.  The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.

Authors:  Makoto Urushibara; Hiroshi Takayanagi; Takako Koga; Sunhwa Kim; Miho Isobe; Yasuyuki Morishita; Takumi Nakagawa; Monika Löeffler; Tatsuhiko Kodama; Hisashi Kurosawa; Tadatsugu Taniguchi
Journal:  Arthritis Rheum       Date:  2004-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.